Name
|
Steroid Receptor Co-Factor Peptide
|
Code
|
|
The alias
|
Steroid Receptor Co-Factor Peptide
|
Sequence (single letter abbreviation)
|
LTERHKILHRLLQE
|
Sequence (three-letter abbreviation)
|
H-Leu-Thr-Glu-Arg-His-Lys-Ile-Leu-His-Arg-Leu-Leu-Gln-Glu-OH (trifluoroacetate salt)
|
A basic description
|
This is amino acids 676 to 700 fragment of steroid receptor co-activator (SRC1). This N-terminnaly biotinylated peptide is derived from the second LXXLL motif of SRC1. Co-activator proteins interact with nuclear receptors in a ligand-dependent manner and augment transcription. A short amphipathic betalpha-Helical domain that includes this LXXLL motif serves as the interaction interface between the co-activator molecules and the ligand-dependent activation function (AF-2) located in the COOH-terminus of the nuclear receptor ligand-binding domain (LBD). Receptor binding domain of the co-activator SRC-1 is specifically recruited to the farnesoid X receptor (FXR) ligand-binding domain
|
solubility
|
|
The molecular weight
|
1786.1
|
Chemical formula
|
C79H136N26O21
|
The purity
|
80%,90%,95%,98%,99%
|
Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
Annotation
|
|
Documents
|
|
Figures
|
|
Reference
|
Bramlett, K. et al. Mol. Endocrinol. 15, 909 (2001)
|
The C-terminal
|
|
The N-terminal
|
|
Chemical bridge
|
|